Synergistic effect of a new thromboxane antagonist (GR32191) and heparin on bleeding time in healthy male volunteers

A. De Boer, J.M. Kroon, C.C.M. Kroon, A. Van Vliet, D.D. Breimer, S Donoghue, Adam F. Cohen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Volume29
Issue number5
Publication statusPublished - 15 Oct 1990

Keywords

  • heparin
  • vapiprost
  • bleeding time
  • conference paper
  • controlled study
  • crossover procedure
  • double blind procedure
  • drug potentiation
  • human
  • intravenous drug administration
  • male
  • normal human
  • oral drug administration
  • partial thromboplastin time
  • priority journal
  • thrombocyte aggregation
  • volunteer

Cite this